Explore the year-by-year forecast for Solara Active Pharma Sciences Ltd alongside its financial results and valuation. The estimates depend on the model assumptions; use the ranges and the evidence behind them when comparing scenarios.
The next market-day median forecast for Solara Active Pharma Sciences Ltd (2026-09-23) is ₹534.65 which is 15.00% lower than today’s share price of ₹629.00 with a 10–90% range of ₹534.65–₹541.45. The estimate uses available price history, volatility, trend behaviour and intrinsic value gap.
Interactive Share Price Forecast
Choose tomorrow, day after, weekly, monthly or custom trading-day horizons and adjust assumptions to view possible price ranges.
Scenario controls
Uses trading-day intervals for short-term and long-term forecast views.
1 = next market day, 2 = day after, 21 ≈ one trading month.
Scenario adjusts assumptions for cautious, normal or optimistic market conditions.
Wider bands show more uncertainty; narrower bands show central outcomes.
Higher volatility widens the forecast range.
Higher influence gives more weight to intrinsic value in the forecast.
Target date--
Median forecast--
Expected return--
Selected range--
Chance of upside--
Confidence--
Horizon
Target date
Median forecast
Range
Return
Chance of upside
Forecast guide: Explore possible future price ranges using available price history, intrinsic value trend, volatility and valuation gap. Estimates update as fresh market and valuation data become available.
Solara Active Pharma Sciences Ltd – Investor Insights
Valuation StatusiCompares the stock's intrinsic value (calculated from fundamentals like earnings, book value, and growth) with the current market price (CMP). Undervalued = potential buying opportunity. Overvalued = the market may be pricing in too much optimism.
Overvalued
Intrinsic ₹332.17 vs CMP ₹629.00 (-47.2%)
Market RegimeiShows whether the stock is in an uptrend (bullish) or downtrend (bearish) based on its Exponential Moving Average (EMA). When price is above EMA → bullish momentum. Below EMA → bearish pressure. This affects how our model adjusts volatility and predictions.
▲ Bullish
Price/EMA: 1.282 · EMA(252): ₹490.76
VolatilityiMeasures how much the stock price swings. Low (<25%) = stable, predictable price movement. Moderate (25-40%) = normal for most stocks. High (>40%) = large daily swings, higher risk. The "recent trend" shows if volatility is currently increasing or decreasing compared to its historical average.
67.7% annualized
Risk: High · Recent trend: Rising (recent > historical)
Trend MemoryiThe Hurst Exponent measures whether price movements tend to continue (trending) or reverse (mean-reverting). Above 0.55 = momentum persists, recent trends likely to continue. Below 0.45 = price tends to snap back after big moves. Around 0.5 = random walk, past moves don't predict future direction.
Mean-reverting
Hurst exponent: 0.443
Projected CAGRiCompound Annual Growth Rate — the average yearly return if the stock reaches our projected price target. 5Y and 10Y show different time horizons. Higher CAGR = faster expected growth. Negative CAGR = the model projects the stock may decline from current levels.
-1.3%5Y-2.1%10Y
Historical drift: -4.4% annualized
Risk-Reward RatioiCompares your potential upside (to intrinsic value) against potential downside (to fundamental floor). Above 2x = favorable risk-reward, potential gain is at least double the potential loss. Below 1x = unfavorable, you risk losing more than you could gain. A negative value means the stock is already above intrinsic value.
-0.48x
Upside -47.2% vs downside 98% · Unfavourable
Margin of SafetyiA concept from value investing (Benjamin Graham). It measures how much cheaper the stock is compared to its intrinsic value. Positive margin = you're buying below fair value (safety cushion). Negative margin = you're paying more than the stock is fundamentally worth. Most value investors look for at least 15-25% margin of safety.
-89.4%
No margin
Forecast ConfidenceiShows how strongly the forecast is supported by available data, recent forecast behaviour and volatility. Higher confidence means the estimate has better historical support and lower uncertainty.
Moderate (56.4%)
Chance of upside: 0.0% · Avg forecast error: 14.23% · 591 data points
Fundamental FlooriA modelled fundamental reference level based on book value and financial-strength inputs (including ROE, ROCE and debt ratios). It is not a guaranteed price floor: market prices can trade below it when fundamentals change or during stressed conditions.
₹12.58
(98% below CMP)
52-Week Range
iShows the stock's lowest and highest closing prices over the past year (~252 trading days). The marker shows where today's price sits within that range. Near the low = potential value opportunity or ongoing weakness. Near the high = momentum or possible overextension.
₹426.00
₹749.00
CMP: ₹629.0063% into range16% below 52W high
Monthly Return DistributioniBased on historical monthly returns (~21 trading days per month). Shows how many months the stock went up vs down, the best and worst single-month returns, and the win rate. A win rate above 55% with a positive average return indicates consistent performance. High best/worst spread = volatile returns.
Convergence TimelineiShows a possible timeline for the stock price to move closer to its intrinsic value. Milestones show estimated prices at 25%, 50%, 75% and 100% convergence. For overvalued stocks, convergence may indicate downside toward intrinsic value.
Target: ₹332.17 in ~5.0 years (2031)
Now ₹62925% ₹55550% ₹48175% ₹406Target ₹332
Gap: 47.2% downward · Assumed convergence period: 5.0 years
What this means: Solara Active Pharma Sciences Ltd appears overvalued by 47.2% relative to intrinsic value. The stock is currently in a bullish regime (price above EMA). A Hurst exponent of 0.44 suggests mean-reverting behavior — extreme moves tend to reverse. Volatility is high (67.7% annualized), implying wider price swings and higher risk.
Solara Active Pharma Sciences Ltd Year-Wise Share Price Target (2027–2036)
Year
Projected Price (₹)
Growth %
CAGR
2027
649.09
+3.2%
+3.2%
Month
Projected Price (₹)
Jan
648.57
Feb
659.84
Mar
659.07
Apr
652.56
May
658.82
Jun
672.24
Jul
657.64
Aug
652.47
Sep
632.09
Oct
633.64
Nov
651.92
Dec
649.09
2028
612.38
-2.6%
-1.3%
Month
Projected Price (₹)
Jan
647.29
Feb
649.51
Mar
653.27
Apr
652.65
May
654.31
Jun
671.55
Jul
644.53
Aug
642.81
Sep
641.52
Oct
634.37
Nov
613.19
Dec
612.38
2029
541.26
-13.9%
-4.9%
Month
Projected Price (₹)
Jan
621.22
Feb
633.97
Mar
616.52
Apr
622.32
May
615.96
Jun
591.85
Jul
580.83
Aug
572.17
Sep
564.67
Oct
569.54
Nov
569.31
Dec
541.26
2030
553.92
-11.9%
-3.1%
Month
Projected Price (₹)
Jan
547.05
Feb
534.11
Mar
534.10
Apr
544.26
May
548.83
Jun
562.14
Jul
560.08
Aug
573.75
Sep
556.56
Oct
554.57
Nov
551.82
Dec
553.92
2031
589.98
-6.2%
-1.3%
Month
Projected Price (₹)
Jan
569.72
Feb
570.90
Mar
550.39
Apr
558.42
May
547.32
Jun
549.53
Jul
556.37
Aug
559.20
Sep
564.86
Oct
571.25
Nov
565.51
Dec
589.98
2032
563.99
-10.3%
-1.8%
Month
Projected Price (₹)
Jan
572.16
Feb
585.60
Mar
570.81
Apr
575.40
May
586.21
Jun
586.90
Jul
606.72
Aug
595.78
Sep
596.05
Oct
589.84
Nov
578.10
Dec
563.99
2033
524.18
-16.7%
-2.6%
Month
Projected Price (₹)
Jan
549.68
Feb
540.34
Mar
537.44
Apr
535.73
May
539.32
Jun
526.81
Jul
508.45
Aug
498.41
Sep
500.33
Oct
501.58
Nov
514.45
Dec
524.18
2034
554.53
-11.8%
-1.6%
Month
Projected Price (₹)
Jan
533.60
Feb
537.98
Mar
553.23
Apr
544.70
May
537.46
Jun
546.75
Jul
532.50
Aug
533.14
Sep
532.30
Oct
514.49
Nov
530.11
Dec
554.53
2035
512.80
-18.5%
-2.2%
Month
Projected Price (₹)
Jan
534.28
Feb
530.38
Mar
517.44
Apr
534.87
May
521.15
Jun
524.54
Jul
517.28
Aug
516.46
Sep
520.23
Oct
530.23
Nov
532.01
Dec
512.80
2036
507.83
-19.3%
-2.1%
Month
Projected Price (₹)
Jan
518.38
Feb
514.74
Mar
518.38
Apr
515.64
May
525.84
Jun
515.95
Jul
522.03
Aug
513.94
Sep
510.45
Oct
497.02
Nov
502.12
Dec
507.83
Advertisements
Solara Active Pharma Sciences Ltd Stock Price Analysis
Avg Error (MAPE)iMean Absolute Percentage Error — the average difference between predicted and actual prices, expressed as a percentage. Lower is better. Below 2% = excellent, 2-5% = good, above 5% = the model struggles with this stock.
5.49%
Direction AccuracyiHow often the model correctly predicted whether the price would go up or down the next day. Above 55% = good (better than a coin flip). Above 60% = strong. This matters more than exact price accuracy for trading decisions.
51.9%
Avg Error (₹)iThe average rupee difference between predicted and actual closing prices. For a ₹100 stock, an error of ₹2 means predictions are typically off by about 2%. This gives you a sense of the prediction's precision in absolute terms.
₹29.57
PredictionsiTotal number of daily forecasts available for this stock. More observations improve the reliability of accuracy metrics and trend comparison.
Will Solara Active Pharma Sciences Ltd share price increase on the next market day?
Solara Active Pharma Sciences Ltd median forecast is ₹534.65 on 2026-09-23, which is 15.00% lower than today’s price of ₹629.00. The 10-90% forecast range is ₹534.65 to ₹541.45. Forecast confidence is 56.4%, with probability-up estimate of 0.0%. This estimate uses Getaka’s price-history, valuation-gap and volatility framework.
What is the intrinsic value of Solara Active Pharma Sciences Ltd?
Solara Active Pharma Sciences Ltd intrinsic value is ₹332.17, which is 47.19% below the current price of ₹629.00. This suggests the stock is currently overvalued.
What is the share price target of Solara Active Pharma Sciences Ltd in 2027?
Solara Active Pharma Sciences Ltd share price target for 2027 is projected to reach ₹649.09 by year-end (range: ₹632.09 to ₹672.24), representing a 3.19% increase from the current price of ₹629.00.
What is the share price target of Solara Active Pharma Sciences Ltd in 2028?
Solara Active Pharma Sciences Ltd share price target for 2028 is projected to reach ₹612.38 by year-end (range: ₹612.38 to ₹671.55), representing a -2.64% decrease from the current price of ₹629.00.
What is the share price target of Solara Active Pharma Sciences Ltd in 2029?
Solara Active Pharma Sciences Ltd share price target for 2029 is projected to reach ₹541.26 by year-end (range: ₹541.26 to ₹633.97), representing a -13.95% decrease from the current price of ₹629.00.
Should I buy Solara Active Pharma Sciences Ltd stock now?
Based on current analysis, Solara Active Pharma Sciences Ltd currently receives a consider reviewing your position research stance from this valuation framework. Intrinsic value is ₹332.17 vs CMP ₹629.00. Use this as a research input and match it with your risk profile, investment horizon and portfolio plan.
What is the fundamental floor price for Solara Active Pharma Sciences Ltd?
The fundamental floor price for Solara Active Pharma Sciences Ltd is ₹12.58, calculated from book value and financial strength metrics (ROE, ROCE, debt-to-equity, interest coverage). This is a modelled reference level rather than a guaranteed minimum, and the market price can trade below it.
Solara Active Pharma Sciences Ltd Share Price Prediction – How We Calculate the Targets
We calculate the share price targets for Solara Active Pharma Sciences Ltd using a combined approach of Geometric Fractional Brownian Motion (GFBM) and the Exponential Moving Average (EMA) for trend analysis. This hybrid model incorporates historical price data, memory effects through the Hurst exponent, and dynamic regime shifts based on the stock's trends. Below are the detailed steps of how these projections are calculated.
Step 1: Calculate the Log Returns
The log returns measure the relative change in stock prices over time. It is calculated as follows:
The log returns are calculated for each consecutive pair of stock prices between the start date (January 4, 2025) and the end date (September 22, 2026).
591 valid data points from the historical price data in the period from January 4, 2025 to September 22, 2026 have been used for the calculations.
Step 2: Calculate the Exponential Moving Average (EMA)
The EMA is a weighted average of past prices that gives more importance to recent prices. It is calculated as follows:
The Hurst exponent measures the "memory" or persistence of the stock price movement. It is calculated as follows:
\[ H = \frac{\log(R/S)}{\log(n)} \]
Step 6: Project Future Share Prices Using GFBM and EMA
The future price of the stock is projected using a combined model of Geometric Fractional Brownian Motion (GFBM) and Exponential Moving Average (EMA) for trend-based regime switching.
Step 7: Predicting Tomorrow's Stock Price for Solara Active Pharma Sciences Ltd
The next market-day price forecast uses price trend, volatility, valuation gap and regime adjustment. The displayed value is the median estimate, supported by a 10–90% uncertainty range.
Step 8: Projected Share Prices for the Next 10 Years
The projected share prices for the next 10 years are calculated using the combined GFBM and EMA model, taking into account historical growth, volatility, and market trends.
Conclusion
Our hybrid approach provides a realistic projection of share prices for Solara Active Pharma Sciences Ltd over the next 10 years by considering historical performance, volatility, market memory, and current trends.
How to assess Solara Active Pharma Sciences Ltd share price targets
Compare the growth and valuation assumptions with reported profitability, debt and operating cash flow. A higher projected price needs supporting business performance; weaker earnings or a lower valuation multiple can produce a different outcome.
Targets are model outputs, not promises. The page should be read together with valuation, profitability, balance-sheet risk, volatility and forecast-error information. Read the forecasting methodology.
The projected stock prices are informational estimates based on available data and assumptions. Past performance does not guarantee future results. Investors should consider risk profile, investment horizon, portfolio allocation and market risks before acting on any research output. Please read all relevant documents and terms carefully before investing.